-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Ayala Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
- Ayala Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2023 was -$24.7M, a 153% decline year-over-year.
- Ayala Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2023 was -$48.1M, a 26.5% decline year-over-year.
- Ayala Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$48.1M, a 26.5% decline from 2022.
- Ayala Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$38M, a 113% decline from 2021.
- Ayala Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$17.9M, a 32.5% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)